Bioxytran Inc
(BIXT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,380 | -4,563 | -2,667 | -4,528 | -2,543 |
| Depreciation Amortization | 686 | 357 | 323 | 77 | 259 |
| Other Working Capital | 1,226 | 3,202 | 308 | 2,171 | 263 |
| Other Operating Activity | 412 | 229 | 232 | 583 | 922 |
| Operating Cash Flow | $-56 | $-775 | $-1,804 | $-1,697 | $-1,099 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | -28 | -44 | -32 | -37 | -10 |
| Other Investing Activity | -28 | -44 | -32 | -37 | -10 |
| Investing Cash Flow | $-28 | $-44 | $-32 | $-37 | $-10 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 1,381 | 1,165 | 264 |
| Common Stock Issued | 63 | 550 | 678 | 600 | 950 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -233 |
| Financing Cash Flow | $63 | $550 | $2,059 | $1,765 | $981 |
| Beginning Cash Position | 26 | 295 | 72 | 42 | 170 |
| End Cash Position | 5 | 26 | 295 | 72 | 42 |
| Net Cash Flow | $-21 | $-269 | $223 | $31 | $-128 |
| Free Cash Flow | |||||
| Operating Cash Flow | -56 | -775 | -1,804 | -1,697 | -1,099 |
| Free Cash Flow | -56 | -775 | -1,804 | -1,697 | -1,099 |